A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chromosomal Microarray, Hematologic Malignancy, ClariSure® Oligo-SNP
Test Code90961
CPT Codes
81277
Preferred Specimen
3 mL bone marrow collected in a sodium heparin (green-top) tube
Minimum Volume
1 mL bone marrow • 3 mL peripheral blood
Other Acceptable Specimens
Bone marrow collected in: Sodium heparin (royal blue-top) tube, sodium heparin lead free (tan-top) tube, EDTA (lavender-top) tube, or ACD solution A or B (yellow-top) tube
5 mL peripheral blood collected in: Sodium heparin (green-top) tube, sodium heparin (royal blue-top) tube, sodium heparin lead free (tan-top) tube, EDTA (lavender-top) tube, or ACD solution A or B yellow-top) tube
5x5 tumor biopsy collected in a transport media
5 mL peripheral blood collected in: Sodium heparin (green-top) tube, sodium heparin (royal blue-top) tube, sodium heparin lead free (tan-top) tube, EDTA (lavender-top) tube, or ACD solution A or B yellow-top) tube
5x5 tumor biopsy collected in a transport media
Instructions
Solid tumor specimen requirement: Submit a tumor biopsy in a transport medium (available upon request). Alongside send the pathology report with the diagnosis/clinical indication.
Note:
See genetics specimen collection section for detailed specimen instructions.
Note:
See genetics specimen collection section for detailed specimen instructions.
Transport Temperature
Room temperature
Specimen Stability
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Methodology
Oligo-SNP Array
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 10-12 days
Clinical Significance
To integrate the microarray in the investigation of neoplasms to assess genomic alterations and overall genomic complexity of the abnormal clone. To be used in conjunction with other established clinical laboratory tests for the malignancy in question.